Delivery Order SPE2DB20D1100-SPE2DB24FD5R1
Award Date
8/30/24
Potential Completion Date
9/3/24
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,863.66 and is a delivery order for ORILISSA 150 MG TABLET 7S. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $8,620.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Orilissa 150 mg tablets. The $4,674.67 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distributor Amerisourcebergen Corporation. The $2,745.90 Firm Fixed Price Delivery Order is for the supply of the drug Orilissa 200 mg tablet, with a completion date of June 14, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,705.24, is for the supply of Orilissa 150 mg tablets. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The $2,894.95 contract is for the delivery of the pharmaceutical product Orilissa 150 mg tablets. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,406.31 firm fixed-price delivery order is for the supply of the prescription medication Orilissa 200 mg tablets. The contract has an ultimate completion date of August 13, 2024. While no set-aside designation is mentioned, Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D2001|SPE2DB23FM70E) valued at $13,309.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Orilissa 150 mg tablets with an ultimate completion date of August 25, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORILISSA 150 MG TABLET 7S, a medication, with a ceiling value of $12,606.64 and a performance period through June 6, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,484.68 firm fixed-price delivery order is for Orilissa 150 mg tablets, a prescription medication. The contract award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up...